Endoscopic sleeve gastroplasty with fundal mucosal ablation for weight loss
Official title: Endoscopic Sleeve Gastroplasty With Fundal Mucosal Ablation - a Pilot Study
Run by Chinese University of Hong Kong · NCT06790329 · Data updated 2026-11-12
This study is testing a new weight loss method that combines a procedure called endoscopic sleeve gastroplasty with a technique to reduce a hormone that makes you feel hungry, to see if it helps people lose more weight safely.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 70 Years |
| Sex | All |
| Enrollment | 10 (estimated) |
| Sponsor | Chinese University of Hong Kong Academic / other |
| Locations | 1 site (Shatin) |
| Status | Recruiting |
| Started | January 1, 2025 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2027 |
| Registry record updated | January 24, 2025 |
| Trial ID | NCT06790329 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals with a BMI of 30-40 kg/m2 who have failed standard obesity treatments and are either high-risk for surgery or unwilling to undergo surgical options.
✕Probably not a fit
Patients with previous upper gastrointestinal surgeries or those with certain medical conditions such as severe coagulopathy or uncontrolled endocrine disorders may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pilot study evaluates the effectiveness and safety of combining endoscopic sleeve gastroplasty (ESG) with a new technique of fundal mucosal ablation to enhance weight loss outcomes. ESG is a minimally invasive procedure that mimics the effects of gastric sleeve surgery but traditionally does not affect the gastric fundus, which is linked to ghrelin production. By incorporating fundal ablation, the study aims to reduce fasting plasma ghrelin levels and improve weight loss results. Participants will be monitored for both physiological effects and overall safety during the intervention.
Why it matters
Potential benefit: If successful, this approach could lead to more effective weight loss solutions for patients struggling with obesity.
How similar studies have gone: While ESG has shown promise, the combination with fundal mucosal ablation is a novel approach that has not been extensively tested in previous studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * BMI equal or more than 30kg/m2 (27.5kg/m2 for Chinese or South Asian) to 40kg/m2, or BMI equal or more than 40kg/m2 and patient is either high risk for surgery or unwilling to undergo surgery, AND * failed standard obesity therapy of diet, exercise, behavior modification, and pharmacologic agents either alone or in combination Exclusion Criteria: * Previous upper GI surgery (e.g. bariatric surgery, anti-reflux surgery; gastrectomy; esophageal surgery) * Previous ESG * Gastroparesis * Active smoking * An ongoing or a history of treatment with opioids in the last 12 months prior to enrollment * Previous pyloromyotomy or pyloroplasty * Gastrointestinal obstruction * Use of any medication that may interfere with weight loss or gastric emptying * Severe coagulopathy * Esophageal or gastric varices and/or portal hypertensive gastropathy * Underlying uncontrolled endocrine problem that leads to obesity. (e.g. Hypothyroidism, Cushing syndrome, eating disorder etc.) * Any inflammatory disease of the gastrointestinal tract (including but not limited to severe (LA Grade C or D) esophagitis, active gastric ulceration, active duodenal ulceration, or specific inflammation such as Crohn's disease) * Malignancy * Pregnant or breast feeding * Patients not fit for general anesthesia * ASA grade IV or V * Mental or psychiatric disorder; Drug or alcohol addiction * Other cases deemed by the examining physician as unsuitable for safe treatment * Refusal to participate
Where it's running
-
Chinese University of Hong Kong
Shatin, Hong Kong Recruiting
Study contacts
- Principal investigator: Stephen Ng, FRCSEd(Gen) — Prince of Wales Hospital, the Chinese University of Hong Kong
- Study coordinator: Stephen Ng
- Email: stephenng@surgery.cuhk.edu.hk
- Phone: (852)35052956
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Cognitive changes after bariatric surgery using VR Neurotracker and Neuropsi testing
This study will test whether bariatric surgery combined with virtual‑reality Neurotracker sessions improves thinking and memory in adults with morbid obesity scheduled for surgery.
-
Short-term effects of ultra-processed foods on metabolism
This project will test whether a short-term diet high in ultra-processed foods versus a nutrient- and energy-matched low-UPF diet changes appetite and how much adults with BMI 18.5–30 eat.
-
Validating lab assays, IV catheter techniques, and devices for endocrine, cardiometabolic, and musculoskeletal conditions
This project will test whether laboratory assays, IV catheter methods, and equipment give consistent, reliable results in adults with or without obesity-related, metabolic, or musculoskeletal conditions.
-
Improving team-based biopsychosocial training so clinics can deliver recommended obesity care
This project will test two training methods to help clinic teams (primary care clinicians, behavioral health staff, dietitians, and community health workers) deliver USPSTF-recommended obesity care to patients at Federally Qualified Health Centers.
-
See if same day discharge after bariatric surgery is safe for select patients
This trial tests whether people having sleeve gastrectomy or gastric bypass can go home the same day or should stay at least one night, to see if ER visits within a week differ.
-
Evaluating smoking cessation using e-cigarettes and nicotine therapy
This study is testing whether using e-cigarettes or nicotine replacement therapy can help people with obesity who smoke quit smoking and manage their weight better.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.